CAMBRIDGE, Mass.–(BUSINESS WIRE)–ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that Amit D. Munshi, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 8:30 a.m. PT in San Francisco, CA.
About ReNAgade Therapeutics
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.
To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.
ReNAgade Therapeutics—RNA Without Limits
For more information about the company, its technologies, and its leadership, visit www.renagadetx.com
Contacts
Investor Relations:
Emily Brabbit, Argot Partners
(212) 600-1902
renagade@argotpartners.com
Media Relations:
Sarah Sutton, Argot Partners
(212) 600-1902
renagade@argotpartners.com
Ringing in the New Year, the extended collection promotes moderation and conscious drinking throughout the…
EMEISHAN, CHINA - Media OutReach Newswire - 16 December 2025 - On the evening of…
LONDON, UK - Media OutReach Newswire - 16 December 2025 - Desert diamonds graced the…
SINGAPORE - Media OutReach Newswire - 16 December 2025 - Small and Medium-Sized Accounting Practices…
SYDNEY, AUSTRALIA - Media OutReach Newswire - 16 December 2025 - Leeds Capital and MIO…
Despite 64% reporting revenue growth, 91% of merchants face payment friction HONG KONG SAR -…
